These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil. Ciaparrone M, Quirino M, Schinzari G, Zannoni G, Corsi DC, Vecchio FM, Cassano A, La Torre G, Barone C. Oncology; 2006; 70(5):366-77. PubMed ID: 17179731 [Abstract] [Full Text] [Related]
4. [Significance of thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) activity in breast cancer tissue]. Hakamada Y, Arima M, Misaka T, Yasuda D, Matsunaga T, Kusama M, Aoki T, Sekiguchi N, Koyanagi Y. Gan To Kagaku Ryoho; 2000 Jul; 27(7):1003-10. PubMed ID: 10925685 [Abstract] [Full Text] [Related]
5. Prognostic predictors in breast cancer patients with postoperative 5-fluorouracil-based chemotherapy. Hakamada Y, Tsuchida A, Arima M, Kubouchi T, Tokita H, Ota D, Kaise H, Aoki T, Kusama M, Aoki T. Int J Mol Med; 2005 Aug; 16(2):309-14. PubMed ID: 16012767 [Abstract] [Full Text] [Related]
6. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy. Liersch T, Langer C, Ghadimi BM, Kulle B, Aust DE, Baretton GB, Schwabe W, Häusler P, Becker H, Jakob C. J Clin Oncol; 2006 Sep 01; 24(25):4062-8. PubMed ID: 16943523 [Abstract] [Full Text] [Related]
7. Thymidine kinase and thymidylate synthase in advanced breast cancer: response to tamoxifen and chemotherapy. Foekens JA, Romain S, Look MP, Martin PM, Klijn JG. Cancer Res; 2001 Feb 15; 61(4):1421-5. PubMed ID: 11245445 [Abstract] [Full Text] [Related]
8. [Expressions of thymidine phosphorylase, thymidylate synthase and dihydropyrimidine dehydrogenase in breast cancer and their correlations with prognosis]. Li HX, Zh S, Zhang YH, Risberg B, Karlsson MG, Nesland JM. Zhonghua Zhong Liu Za Zhi; 2004 Nov 15; 26(11):669-72. PubMed ID: 15777505 [Abstract] [Full Text] [Related]
9. [Relationships among the expression of thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase and the prognosis of breast cancer]. Yu ZG, Zhen JH, Jia HY, Zhang Q, Sun JZ. Zhonghua Yi Xue Za Zhi; 2006 Jun 13; 86(22):1558-63. PubMed ID: 16854285 [Abstract] [Full Text] [Related]
10. Immunohistochemical demonstration of fluoropyrimidine-metabolizing enzymes in various types of cancer. Kamoshida S, Shiogama K, Shimomura R, Inada K, Sakurai Y, Ochiai M, Matuoka H, Maeda K, Tsutsumi Y. Oncol Rep; 2005 Nov 13; 14(5):1223-30. PubMed ID: 16211289 [Abstract] [Full Text] [Related]
11. Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer. Jakob C, Aust DE, Meyer W, Baretton GB, Schwabe W, Häusler P, Becker H, Liersch T. J Pathol; 2004 Dec 13; 204(5):562-8. PubMed ID: 15538739 [Abstract] [Full Text] [Related]
12. Establishment of enzyme-linked immunosorbent assays for thymidylate synthase and dihydropyriminide dehydrogenase in cancer tissues. Kurebayashi J, Yamamoto Y, Udagawa K, Okubo S, Fukushima M, Sonoo H. Oncol Rep; 2004 May 13; 11(5):973-9. PubMed ID: 15069534 [Abstract] [Full Text] [Related]
13. Thymidylate synthase and dihydropyrimidine dehydrogenase gene expression in breast cancer predicts 5-FU sensitivity by a histocultural drug sensitivity test. Kakimoto M, Uetake H, Osanai T, Shirota Y, Takagi Y, Takeshita E, Toriya Y, Danenberg K, Danenberg PV, Sugihara K. Cancer Lett; 2005 Jun 01; 223(1):103-11. PubMed ID: 15890242 [Abstract] [Full Text] [Related]
14. TS and DPD mRNA levels on formalin-fixed paraffin-embedded specimens as predictors for distant recurrence of rectal cancer treated with preoperative chemoradiotherapy. Tanaka K, Saigusa S, Toiyama Y, Koike Y, Okugawa Y, Yokoe T, Inoue Y, Kobayashi M, Miki C, Kusunoki M. J Surg Oncol; 2012 May 01; 105(6):529-34. PubMed ID: 22006578 [Abstract] [Full Text] [Related]
15. Expression level of thymidylate synthase mRNA reflects 5-fluorouracil sensitivity with low dose and long duration in primary colorectal cancer. Okumura K, Mekata E, Shiomi H, Naitoh H, Abe H, Endo Y, Kurumi Y, Tani T. Cancer Chemother Pharmacol; 2008 Apr 01; 61(4):587-94. PubMed ID: 17520254 [Abstract] [Full Text] [Related]
16. [A preliminary study on dihydropyrimidine dehydrogenase activity in breast cancer]. Hamaji M, Miyazaki S, Nishida Y, Izukura M, Nishijima J, Oka Y, Seshimo I, Ohwari M. Gan To Kagaku Ryoho; 2000 Oct 01; 27(11):1719-24. PubMed ID: 11057323 [Abstract] [Full Text] [Related]
18. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy. Yamada H, Iinuma H, Watanabe T. Oncol Rep; 2008 Mar 01; 19(3):729-35. PubMed ID: 18288408 [Abstract] [Full Text] [Related]
19. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer. Okumura K, Shiomi H, Mekata E, Kaizuka M, Endo Y, Kurumi Y, Tani T. Oncol Rep; 2006 Apr 01; 15(4):875-82. PubMed ID: 16525674 [Abstract] [Full Text] [Related]
20. Gene expression profile of 5-fluorouracil metabolic enzymes in primary colorectal cancer: potential as predictive parameters for response to fluorouracil-based chemotherapy. Kinoshita M, Kodera Y, Hibi K, Nakayama G, Inoue T, Ohashi N, Ito Y, Koike M, Fujiwara M, Nakao A. Anticancer Res; 2007 Apr 01; 27(2):851-6. PubMed ID: 17465211 [Abstract] [Full Text] [Related] Page: [Next] [New Search]